Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Holders of 5% or more of VNDA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vanda Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.10%4.70M shares | −7.50 ppfrom 15.60% | Feb 5, 20252 filings | Feb 7, 2025 | SEC |
| AQR Capital Management LLC | 13G | 5.82%3.50M shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| Millennium Management LLC | 13G | 5.60%3.38M shares | +2.80 ppfrom 2.80% | Jul 1, 20253 filings | Aug 19, 2026 | SEC |
| State Street Corp | 13G | 5.10%3.02M shares | – | Feb 11, 20212 filings | May 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on Vanda Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 20266:32 PM ET | Millennium Management LLCand 2 others | 13G | 5.60%3.38M shares | +2.80 ppfrom 2.80% | Aug 17, 2026 | SEC |
| Aug 13, 20269:22 AM ET | AQR Capital Management LLCand 1 other | 13G | 5.82%3.50M shares | New | Jun 30, 2026 | SEC |
| May 12, 202612:18 PM ET | State Street Corp | 13G | 5.10%3.02M shares | – | Mar 31, 2026 | SEC |
| Apr 29, 20264:08 PM ET | BlackRock Portfolio Management LLC | 13G/A | 4.20%2.51M shares | −1.30 ppfrom 5.50%Below 5% | Mar 31, 2026 | SEC |
| Mar 27, 20261:55 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Jan 21, 202612:26 PM ET | BlackRock Portfolio Management LLC | 13G/A | 5.50%3.25M shares | −2.20 ppfrom 7.70% | Dec 31, 2025 | SEC |
| Jan 9, 20264:23 PM ET | Millennium Management LLCand 2 others | 13G/A | 2.80%1.68M shares | −2.50 ppfrom 5.30%Below 5% | Dec 31, 2025 | SEC |
| Jul 1, 20254:31 PM ET | Millennium Management LLCand 2 others | 13G | 5.30%3.12M shares | New | Jun 27, 2025 | SEC |
| Apr 15, 20255:04 PM ET | BlackRock Portfolio Management LLC | 13G | 7.70%4.48M shares | New | Mar 31, 2025 | SEC |
| Feb 7, 20251:40 PM ET | BlackRock, Inc. | 13G/A | 8.10%4.70M shares | −7.50 ppfrom 15.60% | Jan 31, 2025 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G/A | 15.60%9.10M shares | – | Dec 31, 2024 | SEC |
| Feb 16, 2021 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Macquarie Group Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | State Street Corp | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vanda Pharmaceuticals Inc. shares.
No Form 144 notices for Vanda Pharmaceuticals Inc. are on file.